Facial Injectors Market Outlook and Opportunities in Grooming Regions with Forecast 2030

Pune, India, February 2023, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Facial Injectors Market.

Market Overview

Global Facial Injectors Market is expected to reach USD 14571.47 Million by 2030, growing with a CAGR of 11.40% during the forecast period (2022-2030). In its report, Market Research Future (MRFR) offers an in-depth look into the market during the review period.

Regional Analysis

Global Facial Injectors Market has been studied in five Key Regions— Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Americas is expected to lead the market with a valuation of USD 4,093.0 million in 2019. The regional market value is projected to reach USD 8,551.9 million at a 9.65% CAGR during the forecast period. The US and Canada are the key country-level markets in the Americas. The regional market growth is primarily attributed to the high demand for facial treatments in the region, which is likely to create additional opportunities for the service providers operating in the facial injectors market in the Americas.

Europe is expected to be the second-largest market with an estimated value of USD 2,995.8 million in 2019 and a projected value of USD 6,420.7 million, registering a 10.0% CAGR during the forecast period. The European facial injectors market includes the UK, Germany, France, Italy, and the Rest of Europe. Prominent players such as Galderma S.A., Merz Pharma, Sinclair Pharma, Sanofi, and Ipsen Pharma are driving market growth in the region. Moreover, due to the increasing number of face-lifts and lip treatments, there will likely be an increased requirement for facial injectors in the region.

Asia-Pacific accounted for the third-largest market share in 2019. The region is expected to be the fastest-growing market for facial injectors during the review period. The Asia-Pacific facial injectors market covers China, Japan, India, Australia, and the rest of Asia-Pacific. The region is gaining prominence in the global healthcare industry and is projected to become the world’s leading market. Additionally, the increasing demand for facial treatments in the region is expected to drive the regional market's growth. The regional facial injectors market is expected to reach USD 3,666.1 million.

The facial injectors market in the Middle East & Africa is expected to reach a valuation of USD 1,016.7 Million. The regional market growth is significantly driven by the presence of major countries, such as the UAE, Saudi Arabia, and Israel. The region has witnessed notable economic growth in the past few years. One of the major factors driving the economy in the region is enhanced healthcare facilities. The demand for facial injectors is expected to increase due to the rapid increase in the number of face-lift and lip treatments in the region.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Facial Injectors Market Research Report

Segmental Analysis

Extensive research has been conducted on the Global Facial Injectors Market, which has been segmented by Type, Application, and End User.

Global Facial Injectors Market has been segmented into dermal fillers/injectable implants and anti-aging/anti-wrinkle injections based on type. The dermal fillers/injectable implants segment is expected to dominate the market with an estimated valuation of USD 4,969.3 million in 2019. The segment is also expected to register a higher CAGR of 10.07% during the forecast period.

By application, the global facial injectors market has been classified into facial line correction treatment, face-lift, lip treatments, and others. The face-lift segment is expected to exhibit the highest CAGR of 10.20% during the forecast period.

The global facial injectors market has been segmented into dermatology clinics & cosmetic centers, hospitals, and others based on end-user. The dermatology clinics & cosmetic centers segment is expected to hold a larger market share and was valued at USD 3,937.0 Million in 2019.

Competitive Analysis

The Prominent Players profiled in the Global Facial Injectors Market are AbbVie Inc. (US), Galderma S.A. (Switzerland), Merz Pharma (Germany), Bausch Health Companies Inc. (Canada), Integra Lifesciences Corporation (US), Sanofi (France), Sinclair Pharma (UK), Suneva Medical, Inc. (US), SciVision Biotech Inc. (Taiwan), Revance Therapeutics, Inc. (US), Merck KGaA (Germany), and Ipsen Pharma. (France).

Mergers, acquisitions, and collaborations are a few of the key growth strategies adopted by these companies to compete in the global market.

Key Developments

In October 2020, Sinclair Pharma entered a partnership with Tamer Group KSA (Saudi Arabia). Under the partnership, Tamer Group KSA will distribute Sinclair Pharma’s products and services in the Middle East.

In October 2019, Galderma S.A. became an independent company after the divestment of Nestle’s Nestlé Skin Health S.A. This enabled the company to strengthen its position in the global healthcare market.